Early Versus Delayed Pancreatic Enzyme Replacement Therapy After Pancreatic Cancer Surgery: A Real-World Cohort Study [0.03%]
早期与晚期胰酶替代治疗在胰腺癌术后患者的疗效：一项真实世界队列研究
Arkadeep Dhali,Jyotirmoy Biswas,Fayaz Khan et al.
Arkadeep Dhali et al.
Objectives: The optimal timing of pancreatic enzyme replacement therapy (PERT) after pancreatic surgery for pancreatic cancer remains uncertain. We compared outcomes after early versus delayed PERT initiation in a real-wo...
Early Economic and Patient-Centered Outcomes Before Spine Metastases Radiation Therapy From an Ongoing Phase II Randomized Controlled Trial [0.03%]
一项正在进行的II期随机对照试验中脊柱转移放射治疗前早期经济和以患者为中心的结果分析
Ena C Oboh,Momina Anwar,Lisa Perry et al.
Ena C Oboh et al.
Objectives: The incidence of metastatic spine cancer is increasing, with up to 40% of patients with metastatic disease developing spine involvement. Radiotherapy options involve conventional external beam radiation therap...
Effect of Treatment Delay on Outcomes With Adjuvant Chemotherapy Versus Chemoradiotherapy in R1-Resected Biliary Tract Cancers [0.03%]
手术切除标本边缘阳性胆道癌辅助化疗与放化疗的治疗延迟对预后的影响：一项倾向评分加权队列研究
Muhammet Ozer,Suleyman Goksu,Timothy J Brown et al.
Muhammet Ozer et al.
Objectives: R1 margins after biliary tract cancer (BTC) resection confer a high recurrence risk. The roles of adjuvant chemoradiotherapy and treatment timing remain incompletely defined. We compared overall survival (OS) ...
The Inpatient Metastatic Spine Score: Prospective Validation on an Ongoing Multicenter Phase II Randomized Controlled Trial [0.03%]
一项前瞻性多中心二期随机对照临床试验中对入院转移性脊椎病评价量表的验证研究
Shearwood McClelland rd
Shearwood McClelland rd
Objectives: The low historical accuracy rate (25%) of Medical Oncology prognosis for inpatients with spinal metastatic disease presents several challenges. This study examines the prognostic accuracy of the Inpatient Meta...
Small Bowel Cancer-Related Mortality in the United States, 1999 to 2024: A CDC WONDER Trend and Forecasting Analysis [0.03%]
1999年至2024年美国小肠癌死亡率的疾病控制与预防中心趋势和预测分析
Arkadeep Dhali,Jyotirmoy Biswas,Ali Shan Hafeez
Arkadeep Dhali
Objectives: Small bowel malignancies are rare, but mortality trends remain incompletely characterized. We assessed national small bowel cancer-related mortality trends in the United States. ...
Xingcan Fan,Tao Yu,Qiuyu Liao et al.
Xingcan Fan et al.
T cell receptor-engineered T cell (TCR-T) therapy represents an innovative tumor immunotherapy. Distinct from CAR-T, it recognizes MHC-restricted antigens to target tumor-specific antigens, exhibiting unique advantages for both solid and he...
American Radium Society (ARS) Appropriate Use Criteria (AUC) for Low-Dose Radiotherapy for Treatment of Osteoarthritis [0.03%]
美国镭学协会(LDR治疗骨关节炎适当使用标准)
Austin Dove,Bobby Koneru,William Small Jr et al.
Austin Dove et al.
Objectives: To summarize current evidence for radiotherapy in the treatment of OA. The population, intervention, comparator, and outcome questions included: What is the role of LDRT for treatment of OA?; What are risks of...
Comorbidity Burden, Treatment, and Survival Among Screen-Detected Lung Cancer Patients: Implications for USPSTF Guidelines [0.03%]
基于人群筛查的肺癌患者伴发疾病负担、治疗及生存状况对美国预防服务工作组指南的意义
Norah Powell,Madeleine Hinojos,Shruti Ayyalasomayajula et al.
Norah Powell et al.
Objectives: Current US Preventive Services Task Force (USPSTF) guidelines for lung cancer screening restrict low-dose chest CT (LDCT) eligibility to those willing to undergo surgery. Little is known about comorbidities, t...
Outcomes With Immunotherapy in Hormone Receptor-Positive Breast Cancer: A Systematic Review and Meta-Analysis [0.03%]
免疫疗法治疗激素受体阳性乳腺癌的疗效：系统性回顾和meta分析
Moazzam Shahzad,Muhammad K Amin,Amir Kasaeian et al.
Moazzam Shahzad et al.
Objectives: Hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2-) breast cancer has historically shown limited response to immunotherapy. We conducted a systematic review and meta-analy...
Combination of Ponatinib and Blinatumomab in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Systematic Review and Meta-Analysis [0.03%]
ponatinib与blinatumomab联合治疗费城染色体阳性急性淋巴细胞白血病的系统评价和 meta 分析
Faiza Fatima,Anurag Jha,Ahmed Raza et al.
Faiza Fatima et al.
Objectives: Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) is traditionally treated with tyrosine kinase inhibitors (TKIs) alongside chemotherapy. Recent studies suggest that combining ponatinib a...